Journal
MEDICINA-LITHUANIA
Volume 55, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/medicina55070336
Keywords
severe asthma; benralizumab; hypereosinophilia; bronchial thermoplasty; eosinophilic chronic rhinosinusitis
Categories
Ask authors/readers for more resources
A 56-year-old man with severe asthma underwent bronchial thermoplasty (BT). However, his asthma exacerbated and hypereosinophilia developed 2 months later, thus necessitating oral corticosteroid (OCS) therapy. Six months after BT, a diagnosis of severe asthma with eosinophilic chronic rhinosinusitis (ECRS) was made and benralizumab treatment was initiated; the blood eosinophil count subsequently decreased and lung function improved, thereby permitting OCS dose tapering. Surprisingly, benralizumab both reduced nasal polyps and ameliorated ECRS. Thus, benralizumab may be a useful drug for the rapid treatment of severe asthma with ECRS, especially in patients with hypereosinophilia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available